# A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing
Canonical URL: https://biopharmsignal.com/news/MARKET/a-father-8217-s-mission-to-save-his-daughter-and-allegations-on-telehealth-glp-1-45b4dd7e
Ticker: MARKET
Company: MARKET
Source: STAT News
Published: 2026-07-23 14:45 EST
Original Source URL: https://www.statnews.com/2026/07/23/readout-loud-podcast-matt-wilsey-rare-disease-lifemd-novo-nordisk-eli-lilly/?utm_campaign=rss
## Summary

Has a wanted fugitive been posing as a biotech executive? And what does it take to develop a therapy for an ultra-rare disease? Find out on this week's episode of "The Readout LOUD" podcast.

## Article Body
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter , and co-hosts STAT’s weekly biotech podcast, The Readout Loud . You can reach Elaine on Signal at elaineywchen.70.

What does it take to develop a therapy for an ultra-rare disease? What are the allegations against a telehealth company that’s partnered with Novo Nordisk? And has a wanted fugitive been posing as a biotech executive?

We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. We speak with our colleagues Jason Mast and Matthew Herper about their impactful look at one father’s mission to develop a treatment for his daughter’s ultra-rare disease. The subject of that feature, Matt Wilsey, also joins us.

We also discuss STAT’s investigation into the GLP-1 prescribing practices of telehealth company LifeMD, as well as other news in the life sciences, including a legal battle between Novo Nordisk and Eli Lilly and the latest revelations on a most-wanted fugitive.

To read the feature on Wilsey, go here ; for more on the investigation into the telehealth company, go here ; to learn more about the fugitive, go here ; and for more on Novo and Lilly’s legal battle, go here .

Be sure to sign up for “The Readout LOUD” on Apple Podcasts , Spotify , or wherever you get your podcasts.
## Recent Company News
- 2026-07-23 16:33 EST — [STAT+: European regulators take steps to bolster clinical trial transparency](https://biopharmsignal.com/news/MARKET/stat-european-regulators-take-steps-to-bolster-clinical-trial-transparency-73aade26) — Source: STAT News
- 2026-07-23 16:23 EST — [STAT+: Popular insulin product enters shortage as other pens leave market](https://biopharmsignal.com/news/MARKET/stat-popular-insulin-product-enters-shortage-as-other-pens-leave-market-c3a6a199) — Source: STAT News
- 2026-07-23 16:18 EST — [Senate health panel delays vote on CDC nominee](https://biopharmsignal.com/news/MARKET/senate-health-panel-delays-vote-on-cdc-nominee-6cfcdaaa) — Source: STAT News
- 2026-07-23 15:26 EST — [STAT+: What’s in the last-minute flurry of health care bills?](https://biopharmsignal.com/news/MARKET/stat-what-s-in-the-last-minute-flurry-of-health-care-bills-39fec163) — Source: STAT News
- 2026-07-23 14:58 EST — [FDA panel confronting peptide controversy](https://biopharmsignal.com/news/MARKET/fda-panel-confronting-peptide-controversy-b9e91564) — Source: STAT News
## Related News
- 2026-07-23 16:33 EST — MARKET — [STAT+: European regulators take steps to bolster clinical trial transparency](https://biopharmsignal.com/news/MARKET/stat-european-regulators-take-steps-to-bolster-clinical-trial-transparency-73aade26)
- 2026-07-23 16:30 EST — BRLI — [OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026](https://biopharmsignal.com/news/BRLI/opko-health-to-report-second-quarter-2026-financial-results-on-july-27-2026-4b38e04c)
- 2026-07-23 16:23 EST — MARKET — [STAT+: Popular insulin product enters shortage as other pens leave market](https://biopharmsignal.com/news/MARKET/stat-popular-insulin-product-enters-shortage-as-other-pens-leave-market-c3a6a199)
- 2026-07-23 16:18 EST — MARKET — [Senate health panel delays vote on CDC nominee](https://biopharmsignal.com/news/MARKET/senate-health-panel-delays-vote-on-cdc-nominee-6cfcdaaa)
- 2026-07-23 15:26 EST — MARKET — [STAT+: What’s in the last-minute flurry of health care bills?](https://biopharmsignal.com/news/MARKET/stat-what-s-in-the-last-minute-flurry-of-health-care-bills-39fec163)